Skip to main content
logo
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
12.63
-1.14 (-8.28%)
Sep 1, 2026, 4:00 PM EDT - Market closed

Kazia Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
1.91.832.4800.0115.18
Revenue Growth
3.81%-26.28%248000.00%-90.00%-99.93%1436.54%
Gross Profit
1.91.832.4800.0115.18
Operating Income
-18.31-14.22-28.46-24.15-25.38-6.38
Net Income
-22.8-20.7-26.78-20.47-25.01-8.42
Earnings Per Share
-10.22-18.89-50.78-55.53-94.42-35.80
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
69.464.351.665.247.3627.59
Total Debt
0.10.40.631.81.84-
Net Cash (Debt)
69.363.951.023.455.5227.59
Net Cash Growth
1656.42%286.02%-70.30%-37.59%-79.99%214.77%
Net Cash Per Share
31.093.601.949.3520.84117.22

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-14.4-13.28-9.58-15.16-22.76-9.11
Capital Expenditures
------
Free Cash Flow
-14.4-13.28-9.58-15.16-22.76-9.11
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-964.22%-777.31%-1147.20%-2414600.00%-253840.00%-42.01%
Pretax Margin
-1285.72%-1227.34%-1090.25%-2073600.00%-253820.00%-58.66%
Profit Margin
-1200.90%-1131.88%-1079.32%-2046500.00%-250140.00%-55.47%
FCF Margin
-758.36%-725.97%-386.17%-1515600.00%-227620.00%-60.01%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
113.965.854.1139743.178458.3411.23